US2003104989A1PendingUtilityA1
Carrier polymers migrating into target organs and drug-containing polymers
Est. expiryFeb 27, 2018(expired)· nominal 20-yr term from priority
A61K 47/645C08G 69/48C08G 69/10A61K 31/559
49
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Polymers derived from polymers represented by Formula (A) (d is 20˜500; and Rs, which may be the same or different, represent each H, alkyl or benzyl) by substituting a part or all of the consisting peptide bonds by (1) hydrazino-Glu (Formula B), and saccharide-modified Glu (Formula C) or by (2) hydorazino-Glu (Formula B), and saccharide-modified Glu (Formula C), and drug bonded Glu (Formula D). These polymers, which are carriers optionally bonded to drugs capable of migrating into target organs (cells), are useful as medicines.
Claims
exact text as granted — not AI-modified1 . A polymer wherein a part of or all of the consisting peptide bonds in the poly-L-glutamic acid of the formula (A)
(wherein, degree of polymerization d is 20˜500, R is hydrogen, C1˜6 alkyl or benzyl, with the proviso that each multiple R may be same or different.) are replaced with the group of the formula
(wherein
(wherein, G is a modified saccharide capable of connecting to hydrazine, m is 1 when is a single bond and m is 0 when is a double bond.)
(wherein, (1) group of the both formula (B) and (C) are essential substituents and when the number of replacement of group of the formula (C) is 2 or more, all the said group are the same.).
2 . A polymer wherein a part of or all of the consisting peptide bonds in the poly-L-glutamic acid of the formula (A)
(wherein, all the symbols are defined as in claim 1 .) are replaced with the group of the formula
(wherein,
is defined as claim 1 ,
(wherein, D is drug, n is 1 when is a single bond, or n is 0 when is a double bond.)
(wherein, (1) group of the both formula (C) and (D) are essential substituents, (2) the number of replacement of group of the formula (C) or (D) is 2 or more, all the said group of the formula (C) or (D) are the same and (3) the number of replacement of group of the formula (B) may be 0.).
3 . A polymer according to claim 1 or 2 , wherein
is
(in each Formula, Q is saccharide chain containing 1˜10 saccharide.).
4 . The polymer according to claim 1 or 2 , wherein
is
5 . A polymer according to claim 2 , wherein D is a drug which is unstable in an alkaline condition.
6 . A polymer according to claim 2 , wherein D is a drug possessing keto group.
7 . A polymer according to claim 2 , wherein D is PGEs.
8 . A polymer according to claim 2 , wherein
is
9 . A polymer according to claim 2 , wherein D is a drug possessing carboxyl group.
10 . A polymer according to claim 2 , wherein
isJoin the waitlist — get patent alerts
Track US2003104989A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.